In Lyme disease endemic areas, initial management of children with arthritis can be challenging because diagnostic tests take several days to return results, leading to potentially unnecessary invasive procedures. Our objective was to examine the role of the C6 peptide enzyme immunoassay (EIA) test to guide initial management.
Published in Pediatrics: https://pediatrics.aappublications.org/content/145/1/e20190593
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31836615